Agilent Technologies completes acquisition of ProZyme

Agilent Technologies Inc. has completed the acquisition of ProZyme, Inc., a leading provider of glycan reagents, kits, and standards. This acquisition expands Agilent’s portfolio of biopharma consumables. The acquisition of ProZyme follows the recent acquisition of Ultra Scientific, a leading provider of chemical standards and certified reference materials. These acquisitions both support Agilent’s long-term strategy to provide customers with more workflow-specific consumables and solutions to help them achieve economic, operational, and scientific success.